Echinacea purpurea (eastern purple coneflower, purple coneflower, hedgehog coneflower, or echinacea) is a North American species of flowering plant in the genus Echinacea of the family Asteraceae. It is native to eastern North America and present to some extent in the wild in much of the eastern, southeastern and midwest United States, as well as in the Canadian Province of Ontario. It is most common in the Ozarks and in the Mississippi and Ohio Valley.
This herbaceous perennial is 120 cm (47 in) tall by 50 cm (20 in) wide at maturity. Depending on the climate, it blooms throughout spring and summer, and into Autumn. Its cone-shaped flowering heads are usually, but not always, purple in the wild. The inflorescence is a capitulum, 7 to 15 cm in diameter, formed by a prominent domed central protuberance consisting of multiple small yellow florets. These are surrounded by a ring of pink or purple ligulate florets. The florets within the flower head are hermaphroditic, having both male and female organs on each flower, while the ligulate florets are sterile.. It is pollinated by butterflies and bees. The alternate leaves, borne by a petiole from 0 to 17 cm, are oval to lanceolate, 5-30 x 5-12 cm; the margin is tightened to toothed.Its habitats include dry open woods, prairies and barrens, as well as cultivated beds. Although the plant prefers loamy, sandy, or well-drained soils in full sun, it is little affected by the soil's pH. E. purpurea produces an achene fruit.
Echinacea is derived from Greek, meaning ‘spiny one’, in reference to the spiny sea urchins which the ripe flower heads of this genus resemble. The epithet purpurea means 'reddish-purple'. Originally named Rudbeckia purpurea by Linnaeus in 1753 in Species plantarum 6, it was reclassified in 1794 by Conrad Moench, in a new genus named Echinacea purpurea (L.) Moench. In 1818, Thomas Nuttall describes a new variety that he named Rudbeckia purpurea var. serotina. Just two decades later, De Candolle raised him to the rank of species of the other genus Echinacea serotina (Nutt.) DC. (1836). In 2002, Binns et al. discovered a misapplication of the name Echinacea purpurea (L.) Moench for the taxon correctly named Echinacea serotina (Nutt.) DC. in 1836. The authors proposed to retain the names not to cause confusion among gardeners and herbalists.
Echinacea purpurea can be propagated either vegetatively or from seeds. Useful vegetative techniques include division, root cuttings, and basal cuttings. Clumps can be divided, or broken into smaller bunches, which is normally done in the spring or autumn. Cuttings made from roots that are "pencil-sized" will develop into plants when started in late autumn or early winter. Cuttings of basal shoots in the spring may be rooted when treated with rooting hormones, such as IBA at 1000 ppm. Seed germination occurs best with daily temperature fluctuations or after stratification, which help to end dormancy. Seeds may be started indoors in advance of the growing season or outdoors after the growing season has started.
Echinacea purpurea is grown as an ornamental plant in temperate regions. It is ideal for curbs, walkways or beds. The flowers can also go into the composition of fresh bouquets. Numerous cultivars have been developed for flower quality and plant form. The cultivars 'Ruby Giant' and Elton Knight='Elbrook' have gained the Royal Horticultural Society's Award of Garden Merit.
Slugs and rabbits will also eat the foliage when young, or shortly after emerging in the spring. Roots can be damaged and eaten by gophers. The fruit is sought after by birds.
Echinacea purpurea contains alkamides, caffeic acid derivatives, polysaccharides, and glycoproteins with purported stimulating effects on the immune system. Nicotiflorin is the dominant flavonoid in E. purpurea, followed by the flavonoid rutin. Native Americans used the plant to treat many ailments, including wounds, burns, insect bites, toothaches, throat infections, pain, cough, stomach cramps, and snake bites. Research has shown how the purple coneflower stimulates the immune system, leading to renewed interest for treating immunodeficiencies, lowering the glycemia and "boosting" healthy immune systems during periods of stress or pandemic, anxiety, and inflammation. Echinacea purpurea is used in pharmaceutics because of its ability to mobilize leukocytes, activate phagocytosis, and stimulate fibroblast formation. It has been implemented in chemotherapy medications and is one of the most widely medically cultivated species of its genus.
Article excerpt is from Wikipedia.org under the Creative Commons License.
Image reused under the GNU Free Documentation License.
Add comment
Comments